Trial Profile
LONG TERM EFFECT AND TOLERANCE OF ULIPRISTAL ACETATE IN Charcot-Marie-TOOTH DISEASE TYPE 1A (UPACOMT)
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 27 Jul 2022
Price :
$35
*
At a glance
- Drugs Ulipristal (Primary)
- Indications Charcot-Marie-Tooth disease
- Focus Pharmacodynamics
- Acronyms UPACOMT
- 06 Oct 2019 According to European Clinical Trials Database record, trial is completed (Global End Date: 26-Feb-2018).
- 24 May 2018 Status changed from recruiting to discontinued.
- 15 May 2017 Status changed from not yet recruiting to recruiting.